Hormones and Behavior
Once the drip started, I felt a little lightheaded and on the verge of dizzy, so Shoko immediately slowed the flow of my drip and I felt fine for the remainder of the experience
Schematic in a created in BioRender
Injection burden 2-3 injections per day on TB-500 days Best for Dose flexibility, injury-focused work Cycle driver GHK-Cu cycling typically sets the cycle length BPC-157 Loading 250-500 mcg/day (weeks 1-4) Frequency Daily Maintenance 250 mcg/day (weeks 5-8+) Route SubQ near injury or oral TB-500 Loading 2.5-5 mg per injection (weeks 1-4) Frequency 2x/week Maintenance 2 mg per injection (weeks 5-8+) Route SubQ systemic GHK-Cu Loading 1-2 mg/day (weeks 1-4) Frequency Daily Maintenance 1 mg/day (weeks 5-8+) Route SubQ Weekly Schedule Example Monday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Tuesday BPC-157 500 mcg + GHK-Cu 1-2 mg Wednesday BPC-157 500 mcg + GHK-Cu 1-2 mg Thursday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Friday BPC-157 500 mcg + GHK-Cu 1-2 mg Saturday BPC-157 500 mcg + GHK-Cu 1-2 mg Sunday BPC-157 500 mcg + GHK-Cu 1-2 mg Use a separate syringe for each compound
In early 2018, the FDA released a safety statement regarding obeticholic acid, used for treating primary biliary cirrhosis, highlighting concerns over liver injury associated with its use
However, a subgroup of patients may show overlapping problems involving undermethylation, low methylation reserve, oxidative stress and impaired mitochondrial resilience
